MiR-19a promotes cell proliferation and invasion by targeting RhoB in human glioma cells

被引:28
|
作者
Chen, Qifu [1 ]
Guo, Wei [2 ]
Zhang, Ying [3 ]
Wu, Yaochen [2 ]
Xiang, Jin [2 ]
机构
[1] Third Peoples Hosp Shenzhen, Dept Neurosurg, Shenzhen 518112, Peoples R China
[2] JiNan Univ, Shenzhen Peoples Hosp, Dept Neurosurg, Clin Med Coll 2, Shenzhen 518020, Peoples R China
[3] JiNan Univ, Shenzhen Peoples Hosp, Dept Neurol, Clin Med Coll 2, Shenzhen 518020, Peoples R China
关键词
Glioma; MiR-19a; Ras homolog family member B (RhoB); Proliferation; Invasion; GASTRIC-CANCER CELLS; GLIOBLASTOMA; MICRORNAS; MECHANISMS; GENES; OVEREXPRESSION; PROGRESSION; CARCINOMA; APOPTOSIS; GROWTH;
D O I
10.1016/j.neulet.2016.06.031
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
MicroRNA-19a (miR-19a) is upregulated in different types of cancers, including gliomas, but its specific role and function in gliomas have yet to be fully elucidated. In this study, we found that miR-19a was significantly upregulated in human glioma tissues and cell lines. Overexpression of miR-19a by a miR-19a mimic promoted glioma cell proliferation and invasion. In contrast, miR-19a inhibitor suppressed cell proliferation and invasion. Furthermore, by a dual-luciferase reporter assay and expression analysis, we determined that Ras homolog family member B was a direct target of miR-19a. Knockdown of Ras homolog family member B could block cell proliferation and invasion induced by the miR-19a mimic. In conclusion, our study demonstrated that miR-19a upregulation is common in gliomas and that suppression of miR-19a expression inhibits cell proliferation and invasion, which indicates that miR-19a may act as an oncogene in gliomas. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:161 / 166
页数:6
相关论文
共 50 条
  • [1] miR-19a promotes invasion and epithelial to mesenchymal transition of bladder cancer cells by targeting RhoB
    Li, Zongwu
    Li, Yuanfang
    Wang, Yueyong
    JOURNAL OF BUON, 2019, 24 (02): : 797 - 804
  • [2] MiR-19a Promotes Migration And Invasion By Targeting RHOB In Osteosarcoma
    Liu, Ruidong
    Shen, Liefeng
    Qu, Niyan
    Zhao, Xia
    Wang, Jialiang
    Geng, Jun
    ONCOTARGETS AND THERAPY, 2019, 12 : 7801 - 7808
  • [3] Long Noncoding RNA H19 Promotes Proliferation and Invasion in Human Glioma Cells by Downregulating miR-152
    Chen, Lei
    Wang, Yuhai
    He, Jianqing
    Zhang, Chunlei
    Chen, Junhui
    Shi, Dongliang
    ONCOLOGY RESEARCH, 2018, 26 (09) : 1419 - 1428
  • [4] Long non-coding RNA PVT1 promotes glioma cell proliferation and invasion by targeting miR-200a
    Zhang, Yonghong
    Yang, Gang
    Luo, Yicheng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (02) : 1337 - 1345
  • [5] MiR-1290 promotes proliferation, migration, and invasion of glioma cells by targeting LHX6
    Yan, Lei
    Cai, Kerui
    Sun, Kai
    Gui, Jinqiu
    Liang, Jun
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (10) : 6621 - 6629
  • [6] miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1
    Li, Chuntao
    Liu, Zhixiong
    Yang, Kui
    Chen, Xin
    Zeng, Yu
    Liu, Jinfang
    Li, Zhenyan
    Liu, Yunsheng
    ONCOTARGET, 2016, 7 (24) : 36247 - 36254
  • [7] Overexpression of miR-1283 Inhibits Cell Proliferation and Invasion of Glioma Cells by Targeting ATF4
    Chen, Hao
    Zhang, Yi
    Su, Hai
    Shi, Hui
    Xiong, Qijiang
    Su, Zulu
    ONCOLOGY RESEARCH, 2019, 27 (03) : 325 - 334
  • [8] miR-92 regulates the proliferation, migration, invasion and apoptosis of glioma cells by targeting neogenin
    Wang, Yi
    Tian, Yaohui
    Li, Zonghao
    Zheng, Zhaoke
    Zhu, Liangliang
    OPEN MEDICINE, 2020, 15 (01): : 283 - 291
  • [9] MiR-338 suppresses cell proliferation and invasion by targeting CTBP2 in glioma
    Liu, De-Zhi
    Zhao, Hui
    Zou, Qin-Guang
    Ma, Qing-Jie
    CANCER BIOMARKERS, 2017, 20 (03) : 289 - 297
  • [10] miR-25-3p promotes glioma cell proliferation and migration by targeting FBXW7 and DKK3
    Peng, Gang
    Yang, Chenxing
    Liu, Yi
    Shen, Chenfu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (01) : 769 - 778